Literature DB >> 12022233

Region-specific alternative splicing in the nervous system: implications for regulation by the RNA-binding protein NAPOR.

Wenqing Zhang1, Haiying Liu, Kyoungha Han, Paula J Grabowski.   

Abstract

Alternative RNA splicing generates extensive proteomic diversity in the nervous system, yet few neural-specific RNA binding proteins have been implicated in splicing control. Here we show that the biochemical properties and spatial expression of mouse neuroblastoma apoptosis-related RNA-binding protein (NAPOR; also called NAPOR-1) are consistent with its roles in the regulation of the exon 5 and exon 21 splicing events of the N-methyl-D-aspartate (NMDA) receptor R1 transcript. NAPOR, which is closely related to CUG binding protein 2 (CUG-BP2), promotes exon 21 and represses exon 5 splicing in functional coexpression assays. These NMDA mRNA isoforms are distributed, in vivo, in a region-specific manner in rat brain, such that high levels of exon 21 selection and exon 5 skipping coincide with high NAPOR mRNA expression in the forebrain. Within the forebrain, this spatial correspondence is most striking in the visual cortex. In contrast, low NAPOR expression coincides with the reciprocal pattern of alternative splicing in the hindbrain. Complementary experiments demonstrate a tissue-specific distribution of NAPOR, CUG-BP, and other highly related proteins within the nervous system as assayed by probing forebrain and hindbrain nuclear extracts with monoclonal antibody, mAb 3B1. Thus, NAPOR may be one of a group of closely related proteins involved in splicing regulation within the brain. An intronic RNA element responsible for the silencing of exon 21 splicing is identified by mutational analysis and shown to bind directly to recombinant NAPOR protein, suggesting a model in which exon 21 selection is positively regulated by an antirepression mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12022233      PMCID: PMC1370287          DOI: 10.1017/s1355838202027036

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  48 in total

Review 1.  Alternative pre-mRNA splicing: the logic of combinatorial control.

Authors:  C W Smith; J Valcárcel
Journal:  Trends Biochem Sci       Date:  2000-08       Impact factor: 13.807

2.  A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing.

Authors:  A D Polydorides; H J Okano; Y Y Yang; G Stefani; R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  Coordinate repression of a trio of neuron-specific splicing events by the splicing regulator PTB.

Authors:  L Zhang; W Liu; P J Grabowski
Journal:  RNA       Date:  1999-01       Impact factor: 4.942

4.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

5.  Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability.

Authors:  K B Jensen; B K Dredge; G Stefani; R Zhong; R J Buckanovich; H J Okano; Y Y Yang; R B Darnell
Journal:  Neuron       Date:  2000-02       Impact factor: 17.173

6.  HuD, a neuronal-specific RNA-binding protein, is a putative regulator of N-myc pre-mRNA processing/stability in malignant human neuroblasts.

Authors:  D L Lazarova; B A Spengler; J L Biedler; R A Ross
Journal:  Oncogene       Date:  1999-04-29       Impact factor: 9.867

7.  Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios.

Authors:  G Tiscornia; M S Mahadevan
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

8.  Developmentally-regulated expression of mNapor encoding an apoptosis-induced ELAV-type RNA binding protein.

Authors:  D K Choi; T Ito; F Tsukahara; M Hirai; Y Sakaki
Journal:  Gene       Date:  1999-09-03       Impact factor: 3.688

9.  hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells.

Authors:  M Y Chou; N Rooke; C W Turck; D L Black
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

10.  Fluorescent differential display analysis of gene expression in apoptotic neuroblastoma cells.

Authors:  D K Choi; T Ito; Y Mitsui; Y Sakaki
Journal:  Gene       Date:  1998-11-26       Impact factor: 3.688

View more
  43 in total

1.  A consensus CaMK IV-responsive RNA sequence mediates regulation of alternative exons in neurons.

Authors:  Jiuyong Xie; Calvin Jan; Peter Stoilov; Jennifer Park; Douglas L Black
Journal:  RNA       Date:  2005-12       Impact factor: 4.942

2.  Distal regulation of alternative splicing by splicing enhancer in equine beta-casein intron 1.

Authors:  Tina Lenasi; B Matija Peterlin; Peter Dovc
Journal:  RNA       Date:  2006-01-23       Impact factor: 4.942

3.  A nuclear function of Hu proteins as neuron-specific alternative RNA processing regulators.

Authors:  Hui Zhu; Robert A Hasman; Victoria A Barron; Guangbin Luo; Hua Lou
Journal:  Mol Biol Cell       Date:  2006-10-11       Impact factor: 4.138

4.  Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein.

Authors:  Natalia Gromak; Arianne J Matlin; Thomas A Cooper; Christopher W J Smith
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

Review 5.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

6.  A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG.

Authors:  Yui Jin; Hitoshi Suzuki; Shingo Maegawa; Hitoshi Endo; Sumio Sugano; Katsuyuki Hashimoto; Kunio Yasuda; Kunio Inoue
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

Review 7.  CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease.

Authors:  Andrea N Ladd
Journal:  Mol Cell Neurosci       Date:  2012-12-14       Impact factor: 4.314

8.  CUGBP2 directly interacts with U2 17S snRNP components and promotes U2 snRNA binding to cardiac troponin T pre-mRNA.

Authors:  Young-Hwa Goo; Thomas A Cooper
Journal:  Nucleic Acids Res       Date:  2009-05-14       Impact factor: 16.971

9.  ETR-3 and CELF4 protein domains required for RNA binding and splicing activity in vivo.

Authors:  Gopal Singh; Nicolas Charlet-B; Jin Han; Thomas A Cooper
Journal:  Nucleic Acids Res       Date:  2004-02-18       Impact factor: 16.971

10.  The neurofibromatosis type I pre-mRNA is a novel target of CELF protein-mediated splicing regulation.

Authors:  Victoria A Barron; Hui Zhu; Melissa N Hinman; Andrea N Ladd; Hua Lou
Journal:  Nucleic Acids Res       Date:  2009-10-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.